Cyrus Harmon - 16 Sep 2025 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role
Director
Signature
/s/ Shane Kovacs, Attorney-in-Fact
Issuer symbol
OLMA
Transactions as of
16 Sep 2025
Transactions value $
-$204,841
Form type
4
Filing time
18 Sep 2025, 21:30:05 UTC
Previous filing
13 Jun 2025
Next filing
29 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Harmon Cyrus Director C/O OLEMA PHARMACEUTICALS, INC., 780 BRANNAN ST, SAN FRANCISCO /s/ Shane Kovacs, Attorney-in-Fact 18 Sep 2025 0001831410

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OLMA Common Stock Sale -$80,400 -10,000 -1.3% $8.04 754,140 16 Sep 2025 Direct F1
transaction OLMA Common Stock Sale -$83,300 -10,000 -1.3% $8.33 744,140 18 Sep 2025 Direct F2
transaction OLMA Common Stock Sale -$15,465 -1,914 -1.6% $8.08 120,114 16 Sep 2025 See Footnote F3, F4
transaction OLMA Common Stock Sale -$25,675 -3,086 -2.6% $8.32 117,028 18 Sep 2025 See Footnote F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average sale price for the transaction reported was $8.04, and the range of prices was between $8.02 and $8.09. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
F2 The weighted average sale price for the transaction reported was $8.33, and the range of prices was between $8.28 and $8.37. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
F3 The weighted average sale price for the transaction reported was $8.08, and the range of prices was between $8.04 and $8.08. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
F4 The shares are held by the Harmon Family Investors LLC, of which the Reporting Person is the manager.
F5 The weighted average sale price for the transaction reported was $8.32, and the range of prices was between $8.29 and $8.33. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.